Bonus BioGroup Ltd. (BBIXF)

OTCMKTS · Delayed Price · Currency is USD
0.0400
0.00 (0.00%)
At close: Jul 7, 2025
33.33%
Market Cap88.62M
Revenue (ttm)n/a
Net Income (ttm)-7.64M
Shares Outn/a
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume38,500
Average Volume8,649
Open0.0400
Previous Closen/a
Day's Range0.0400 - 0.0400
52-Week Range0.0001 - 0.0500
Beta0.89
RSI53.73
Earnings DateMay 29, 2025

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 49
Stock Exchange OTCMKTS
Ticker Symbol BBIXF
Full Company Profile

Financial Performance

Financial numbers in ILS Financial Statements

News

There is no news available yet.